相关实验视频

Updated: Jun 15, 2025

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

880

实时听觉反用于改善帕金森病患者的步态和步行:试点和可行性试验

Nancy E Mayo1,2, Kedar K V Mate3,4, Lesley K Fellows4,5

  • 1Department of Medicine, School of Physical and Occupational Therapy, Faculty of Medicine, McGill University, Center for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Center (MUHC), Montreal, QC, Canada. nancy.mayo@mcgill.ca.

Pilot and feasibility studies
|August 27, 2024
PubMed
概括

在帕金森病患者中,Heel2ToeTM传感器显示了改善行走的潜力. 这种可穿戴技术在3个月的时间内在6分钟步行测试和步行质量方面取得了显著的进展.

关键词:
有关反的意见反.步行方式 步行方式帕金森病是帕金森氏症的一种疾病.试点研究试点研究可以穿戴的可穿戴设备.

更多相关视频

Movement Retraining using Real-time Feedback of Performance08:16

Movement Retraining using Real-time Feedback of Performance

Published on: January 17, 2013

13.4K
Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits06:25

Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits

Published on: August 12, 2019

8.5K

相关概念视频

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500